Global Microbial Amendment Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Agriculture
Publisher : MRA | Format : PDF
Global Microbial Amendment Market Insights, Forecast to 2034
Global Microbial Amendment market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Microbial Amendment industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, Microbial Amendment key manufacturers include Novozymes A/S, BASF SE, Bayer AG, Syngenta AG, DowDuPont, Marrone Bio Innovations, Inc., Valent BioSciences LLC, Verdesian Life Sciences and Chr. Hansen A/S, etc. Novozymes A/S, BASF SE, Bayer AG are top 3 players and held % sales share in total in 2022.
For production bases, global Microbial Amendment production is dominated by and . The two regions contributed to % production share globally in 2022 and the proportion will reach to % in 2033.
When considering the consumption regions, % volume of Microbial Amendment were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the sales share will be % in 2033. Moreover, China, plays a key role in the whole Microbial Amendment market and estimated to attract more attentions from industry insiders and investors.
Microbial Amendment can be divided into Liquid and Powder, etc. Liquid is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2033.
Microbial Amendment is widely used in various fields, such as Soil Treatment, Seed Treatment and Other,, etc. Soil Treatment provides greatest supports to the Microbial Amendment industry development. In 2022, global % sales of Microbial Amendment went into Soil Treatment filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Microbial Amendment market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Microbial Amendment market with multiple angles. Items like regional production, sales, revenue from 2018 to 2033 and manufacturers’ capacity, sales, price, revenue and gross margin from 2018 to 2023 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
Novozymes A/S
BASF SE
Bayer AG
Syngenta AG
DowDuPont
Marrone Bio Innovations, Inc.
Valent BioSciences LLC
Verdesian Life Sciences
Chr. Hansen A/S
Segment by Type
Liquid
Powder
Soil Treatment
Seed Treatment
Other
North America
Europe
China
Japan
Sales by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional production volume analysis from 2018 to 2033
Chapter 3Regional revenue and sales volume analysis from 2018 to 2033
Chapter 4Manufacturers’ sales, revenue and price analysis, including manufacturers’ Microbial Amendment plant distribution, commercial date of Microbial Amendment, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 5Product sales, revenue and price analysis by type from 2018 to 2033 globally
Chapter 6Product sales, revenue and price analysis by application from 2018 to 2033 globally
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2033 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2033 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2033
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2033 in China. Product sales and revenue analysis of China from 2018 to 2033
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 11Product sales, revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 12Manufacturers’ outline, covering company’s basic information, major business, Microbial Amendment introduction, etc. Microbial Amendment Capacity, Sales, Revenue, Price and Gross Margin of each company from 2018 to 2023
Chapter 13Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 14Market opportunities and challenges analysis
Chapter 15MRAResearch’s Conclusions of Microbial Amendment
Chapter 16Methodology and Data Sources adopted by MRAResearch
Globally, Microbial Amendment key manufacturers include Novozymes A/S, BASF SE, Bayer AG, Syngenta AG, DowDuPont, Marrone Bio Innovations, Inc., Valent BioSciences LLC, Verdesian Life Sciences and Chr. Hansen A/S, etc. Novozymes A/S, BASF SE, Bayer AG are top 3 players and held % sales share in total in 2022.
For production bases, global Microbial Amendment production is dominated by and . The two regions contributed to % production share globally in 2022 and the proportion will reach to % in 2033.
When considering the consumption regions, % volume of Microbial Amendment were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the sales share will be % in 2033. Moreover, China, plays a key role in the whole Microbial Amendment market and estimated to attract more attentions from industry insiders and investors.
Microbial Amendment can be divided into Liquid and Powder, etc. Liquid is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2033.
Microbial Amendment is widely used in various fields, such as Soil Treatment, Seed Treatment and Other,, etc. Soil Treatment provides greatest supports to the Microbial Amendment industry development. In 2022, global % sales of Microbial Amendment went into Soil Treatment filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Microbial Amendment market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Microbial Amendment market with multiple angles. Items like regional production, sales, revenue from 2018 to 2033 and manufacturers’ capacity, sales, price, revenue and gross margin from 2018 to 2023 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Novozymes A/S
BASF SE
Bayer AG
Syngenta AG
DowDuPont
Marrone Bio Innovations, Inc.
Valent BioSciences LLC
Verdesian Life Sciences
Chr. Hansen A/S
Segment by Type
Liquid
Powder
Segment by Application
Soil Treatment
Seed Treatment
Other
Production by Region
North America
Europe
China
Japan
Sales by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional production volume analysis from 2018 to 2033
Chapter 3Regional revenue and sales volume analysis from 2018 to 2033
Chapter 4Manufacturers’ sales, revenue and price analysis, including manufacturers’ Microbial Amendment plant distribution, commercial date of Microbial Amendment, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 5Product sales, revenue and price analysis by type from 2018 to 2033 globally
Chapter 6Product sales, revenue and price analysis by application from 2018 to 2033 globally
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2033 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2033 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2033
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2033 in China. Product sales and revenue analysis of China from 2018 to 2033
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 11Product sales, revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 12Manufacturers’ outline, covering company’s basic information, major business, Microbial Amendment introduction, etc. Microbial Amendment Capacity, Sales, Revenue, Price and Gross Margin of each company from 2018 to 2023
Chapter 13Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 14Market opportunities and challenges analysis
Chapter 15MRAResearch’s Conclusions of Microbial Amendment
Chapter 16Methodology and Data Sources adopted by MRAResearch